gregmushen on why AI's exponential progress can't bypass biology's empirical bottlenecks

gregmushen · x · 2026-10-12

In a lengthy X debate with @reallyoptimized, gregmushen lays out a three-question framework for why AI won't simply shortcut medical breakthroughs:

His core argument: people correctly predict #1 (exponential model progress) but overlook that #1 remains subject to #2 and #3, which don't inherently benefit from technology S-curves — leading to overestimated impact and underestimated timelines.

Citing NHANES, BIOBANK and thousands of RCTs, he argues existing observational data can find correlations but cannot establish causal effects of novel interventions: if ASI invented a cellular-reprogramming therapy tomorrow, the number of people in any dataset who received it would be exactly zero. His interlocutor counters that new, currently incomprehensible evidentiary standards will emerge and biology may become an information technology; gregmushen insists any replacement standard itself requires empirical evaluation, and progressive human-subject testing remains unavoidable.

Related event: Quantum Advances Won't Bypass Empirical Bottleneck in AI Drug Discovery, Arguer Says(3 posts)→

Original post →

More from AGI Musings

AGI Musings channel →